Navigation Links
Max Neeman International Adds to Existing Six Sigma, SOP Training
Date:3/27/2013

RESEARCH TRIANGLE PARK, N.C., March 27, 2013 /PRNewswire/ -- Max Neeman International, a leading Asia-Pacific CRO, has announced successful completion of its first MAXimizer project focused on the Data Management validation process.  This project was designed to increase the identification of discrepancies at the first level of data cleaning.  A post-training pilot study showed 20% improvement in the performance of level 1 data cleaning, proving MAXimizer to be an excellent quality improvement tool. 

MAXimizer is an enterprise wide initiative to empower employees in any department, with problem solving methodology, using various tools and techniques based on the Six Sigma principles.  CEO Dr. Ajoy Kumar strongly advocates use of Six Sigma principles in the organization along with global and departmental SOPs, regular internal audits for quality control and client assurance.  International Quality Certifications include:

  • Quality Management System [ISO 9001:2008]
  • Information Security Management System [ISO 27001:2005]
  • Management System for Clinical Investigation of Medical Devices [ISO 14155:2001]
  • Malcolm Baldrige Performance Excellence Program

Every employee must undergo regular trainings and exposure to the latest developments in their areas of expertise as Max Neeman is a 'Knowledge Contract Research' company overall. 

Training ranges from technical to non-technical topics of:

  • ICH GCP guidelines
  • Protocol-specific training
  • Regulatory scenario in various Asia-Pac countries
  • Project Management workshops
  • QA & QC in clinical trials
  • Soft skills development workshops

Continuous training and QA/QC procedures have been an integral part of Max Neeman 's corporate culture since operations began in 2001. 

About Max Neeman International
Max Neeman International is a leading Asia-Pacific CRO with India expertise and expanded capabilities into N. America and Europe. For over a decade, the company has provided clinical research services for the successful conduct of Phase II-IV drug and device trials to Pharmaceutical, Biotech, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. ' Max Neeman ' is ISO 9001:2008 certified for monitoring, site management and data management with over >400 employees, 200 active sites in various therapeutic areas and 304 trials awarded. Data Management services alone have touched 60 countries to date.  For more information contact Donald Swankie , Vice President USA:  donald.swankie@neeman-medical.com or go to www.neeman-medical.com.

 


'/>"/>
SOURCE Max Neeman International
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
4. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
5. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
6. Chindex International, Inc. to Report First Quarter 2012 Financial Results
7. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
8. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
9. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
10. Bacterin International Signs Its Third National GPO Contract with Novation
11. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... WARSAW, Ind., July 27, 2017  Zimmer Biomet Holdings, ... the quarter ended June 30, 2017.  The Company reported ... of 1.1% over the prior year period, and an ... approximately 240 basis points of contribution from the LDR ... from the second quarter of 2016, or 0.3% on ...
(Date:7/26/2017)... Fla. , July 26, 2017 Sancilio ... enrollment of our clinical trial evaluating Altemia TM , ... Anemia (SCA) and Sickle Cell Disease (SCD). The SCOT ... evaluate the efficacy and safety of Altemia TM ... is conducted under US IND 125274. ...
(Date:7/24/2017)... N.Y. , July 24, 2017 IBM (NYSE: ... the Gartner Magic Quadrant for Solid-State Arrays (SSA) for the ... According to Gartner, "Vendors in the Leaders ... and Completeness of Vision. A vendor in the Leaders quadrant ... needed to drive the acceptance of new technologies. These vendors ...
Breaking Medicine Technology:
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... TopConsumerReviews.com recently ... Lab Testing . , The healthcare industry in the United States has undergone ... are the days of needing to have a doctor’s order to get a blood ...
(Date:8/16/2017)... Petaluma, CA (PRWEB) , ... August 16, 2017 ... ... donate and distribute $100,000 in AED (Automated External Defibrillator) machines to their local ... an AED device from Arrow Benefits Group. AED machines are an integral part ...
(Date:8/16/2017)... ... ... of A Child” is the creation of published author, Pauline DiBenedetto. , “As my mother ... was in such great pain, my mother thought that her time has come. Once I ... I was about eight years old, when I had a vision of my own, that ...
(Date:8/15/2017)... Los Angeles, CA (PRWEB) , ... August 15, 2017 , ... The city of Los ... styles exist in harmony with “Cali Style”. LA’s Top Style List, a website that spotlights ... to help the public wear their wardrobe all year long. , According to the senior ...
(Date:8/15/2017)... ... August 15, 2017 , ... The V Foundation ... 19th Annual V Foundation Wine Celebration raised nearly $9 million for cancer research ... million in “Fund-A-Need” donations to support the study of BRCA mutation research in ...
Breaking Medicine News(10 mins):